Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal primary central nervous system lymphoma: Case report and literature review.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2018
Same author

miR-24-p53 pathway evoked by oxidative stress promotes lens epithelial cell apoptosis in age-related cataracts.

Molecular medicine reports·2018
Same author

Porcine Epidemic Diarrhea Virus-Induced Epidermal Growth Factor Receptor Activation Impairs the Antiviral Activity of Type I Interferon.

Journal of virology·2018
Same author

Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling.

Oncotarget·2018
Same author

The role of curcumae rhizoma-sparganii rhizoma medicated serum in epithelial-mesenchymal transition in the triple negative breast cancer: Pharmacological role of CR-SR in the TBNC.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2018
Same author

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.

World journal of gastroenterology·2018

Related Experiment Video

Updated: Jan 14, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.8K

Single-cell and spatial transcriptomics integration: new frontiers in tumor microenvironment and cellular

Wenxin Shi1,2,3, Zhiqiang Zhang1,2, Xiaotong Xu1,2

  • 1Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Frontiers in Immunology
|October 20, 2025
PubMed
Summary

Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) together reveal cancer complexity. Integrating these technologies enhances understanding of the tumor microenvironment for precision oncology.

Keywords:
cancer heterogeneityintercellular communicationsingle-cell RNA sequencingspatial transcriptomicstumor microenvironment

More Related Videos

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

9.8K
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

6.0K

Related Experiment Videos

Last Updated: Jan 14, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.8K
Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
06:05

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

9.8K
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

6.0K

Area of Science:

  • Cancer Biology
  • Genomics
  • Bioinformatics

Background:

  • Single-cell RNA sequencing (scRNA-seq) offers high-resolution cellular insights but lacks spatial context.
  • Spatial transcriptomics (ST) complements scRNA-seq by preserving spatial information within tissues.
  • The tumor microenvironment (TME) is a complex ecosystem critical for cancer progression.

Purpose of the Study:

  • To review the integration of scRNA-seq and ST for TME analysis.
  • To highlight how these technologies uncover cellular heterogeneity and interactions.
  • To discuss computational strategies for spatial multi-omics data integration.

Main Methods:

  • Review of current literature on scRNA-seq and ST integration.
  • Emphasis on computational approaches like deconvolution and mapping.
  • Evaluation of applications in characterizing TME components and functions.

Main Results:

  • Combined scRNA-seq and ST reveal cellular heterogeneity and spatial organization within the TME.
  • These integrated approaches identify stromal-immune interactions and spatial niches driving tumor progression.
  • Computational strategies enable detailed characterization of immune evasion, fibroblast diversity, and cell-cell communication.

Conclusions:

  • The integration of scRNA-seq and ST is transformative for understanding the TME.
  • Spatial multi-omics hold promise for advancing precision oncology with new biomarkers.
  • Bridging the gap between analytical innovation and clinical implementation is crucial for realizing the full potential of these technologies.